AngioDynamics, Inc.
ANGO
$10.36
$0.383.81%
NASDAQ
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 307.31M | 300.72M | 292.50M | 283.32M | 286.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 307.31M | 300.72M | 292.50M | 283.32M | 286.50M |
| Cost of Revenue | 139.59M | 137.88M | 134.79M | 129.32M | 135.49M |
| Gross Profit | 167.72M | 162.84M | 157.71M | 154.00M | 151.01M |
| SG&A Expenses | 150.62M | 149.69M | 145.60M | 143.91M | 143.86M |
| Depreciation & Amortization | 10.48M | 10.40M | 10.32M | 10.30M | 10.99M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 327.98M | 323.97M | 316.56M | 309.55M | 317.68M |
| Operating Income | -20.67M | -23.25M | -24.06M | -26.23M | -31.18M |
| Income Before Tax | -27.71M | -32.21M | -34.03M | -42.06M | -237.39M |
| Income Tax Expenses | -2.00K | -107.00K | -39.00K | -671.00K | -12.67M |
| Earnings from Continuing Operations | -27.71 | -32.10 | -33.99 | -41.39 | -224.72 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.71M | -32.10M | -33.99M | -41.39M | -224.72M |
| EBIT | -20.67M | -23.25M | -24.06M | -26.23M | -31.18M |
| EBITDA | -150.00K | -1.61M | -1.66M | -1.85M | -5.60M |
| EPS Basic | -0.67 | -0.78 | -0.83 | -1.02 | -5.58 |
| Normalized Basic EPS | -0.24 | -0.27 | -0.28 | -0.30 | -0.46 |
| EPS Diluted | -0.68 | -0.79 | -0.84 | -1.02 | -5.58 |
| Normalized Diluted EPS | -0.24 | -0.27 | -0.28 | -0.30 | -0.46 |
| Average Basic Shares Outstanding | 164.55M | 163.93M | 163.41M | 162.86M | 162.24M |
| Average Diluted Shares Outstanding | 164.55M | 163.93M | 163.41M | 162.86M | 162.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |